L-type calcium channels, in the renal microcirculatory response to endothelin

American Journal of Physiology - Renal Physiology

Volumn 288, Issue 4 57-4, 2005, Pages

  Pollock, David M ^a   Jenkins, John M ^a   Cook, Anthony K ^a   Imig, John D ^a   Inscho, Edward W ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Afferent arteriole; Calcium channel blockers; Endothelin receptors; Renal blood flow

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; ENDOTHELIN 1; NIFEDIPINE; SARAFOTOXIN S6C;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; JUXTAGLOMERULAR APPARATUS; KIDNEY BLOOD FLOW; KIDNEY CIRCULATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; VASOCONSTRICTION;

EID: 15044341328     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00315.2004     Document Type: Article

References (38)

1. Cao LQ and Banks RO. Cardiovascular and renal actions of endothelin: effects of calcium-channel blockers. Am J Physiol Renal Fluid Electrolyte Physiol 258: F254-F258, 1990.
2. Carmines PK and Navar LG. Disparate effects of Ca channel blockade on afferent and efferent arteriolar responses to ANG II. Am J Physiol Renal Fluid Electrolyte Physiol 256: F1015-F1020, 1989.
3. Casellas D and Navar LG. In vitro perfusion of juxtamedullary nephrons in rats. Am J Physiol Renal Fluid Electrolyte Physiol 246: F349-F358, 1984.
4. A-receptor blockade in angiotensin II-induced hypertension. Hypertension 29: 435-441, 1997.
5. Edwards RM, Trizna W, and Ohlstein EH. Renal microvascular effects of endothelin. Am J Physiol Renal Fluid Electrolyte Physiol 259: F217-F221, 1990.
6. B receptor-mediated constriction in the renal microcirculation of rats. J Physiol 497: 211-218, 1996.
7. Epstein M and Loutzenhiser RD. Effects of calcium antagonists on renal hemodynamics. Am J Kidney Dis 16: 10-14, 1990.
8. Fellner SK and Arendshorst WJ. Endothelin A and B receptors of preglomerular vascular smooth muscle cells. Kidney Int 65: 1810-1817, 2004.
9. Feng JJ and Arendshorst WJ. Calcium signaling mechanisms in renal vascular responses to vasopressin in genetic hypertension. Hypertension 30: 1223-1231, 1997.
10. Gordienko DV, Clausen C, and Goligorsky MS. Ionic currents and endothelin signaling in smooth muscle cells from rat renal resistance arteries. Am J Physiol Renal Fluid Electrolyte Physiol 266: F325-F341, 1994.
11. 2+ channel in vascular smooth muscle. Proc Natl Acad Sci USA 86: 3915-3918, 1989.
12. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450, 1985.
13. Inscho EW, Cook AK, Mui V, and Imig JD. Calcium mobilization contributes to pressure-mediated afferent arteriolar vasoconstriction. Hypertension 31: 421-428, 1998.
14. 2-purinoceptor agonists. Am J Physiol Renal Physiol 274: F718-F727, 1998.
15. Inscho EW, LeBlanc EA, Pham BT, White SM, and Imig JD. Purinoceptor-mediated calcium signaling in preglomerular smooth muscle cells. Hypertension 33: 195-200, 1999.
16. Inscho EW, Mason MJ, Schroeder AC, Deichmann PC, Stiegler KD, and Imig JD. Agonist-induced calcium regulation in freshly isolated renal microvascular smooth muscle cells. J Am Soc Nephrol 8: 569-579, 1997.
17. Inscho EW, Ohishi K, Cook AK, Belott TP, and Navar LG. Calcium activation mechanisms in the renal microvascular response to extracellular ATP. Am J Physiol Renal Fluid Electrolyte Physiol 268: F876-F884, 1995.
18. Inscho EW, Ohishi K, and Navar LG. Effects of ATP on pre- and postglomerular juxtamedullary microvasculature. Am J Physiol Renal Fluid Electrolyte Physiol 263: F886-F893, 1992.
19. 2+ signaling in preglomerular smooth muscle cells. Am J Physiol Renal Physiol 276: F450-F456, 1999.
20. 2+ influx in A7r5 rat smooth muscle cells: involvement of two different types of channel. J Physiol 503: 237-251, 1997.
21. Kasuya Y, Takuwa Y, Yanagisawa M, Masaki T, and Goto K. A pertussis toxin-sensitive mechanism of endothelin action in porcine coronary artery smooth muscle. Br J Pharmacol 107: 456-462, 1992.
22. Loutzenhiser R, Epstein M, Hayashi K, and Horton C. Direct visualization of effects of endothelin on the renal microvasculature. Am J Physiol Renal Fluid Electrolyte Physiol 258: F61-F68, 1990.
23. Mitchell KD and Navar LG. Tubuloglomerular feedback responses during peritubular infusions of calcium channel blockers. Am J Physiol Renal Fluid Electrolyte Physiol 258: F537-F544, 1990.
24. Navar LG, Inscho EW, Majid SA, Imig JD, Harrison-Bernard LM, and Mitchell KD. Paracrine regulation of the renal microcirculation. Physiol Rev 76: 425-536, 1996.
25. B-receptors in the human saphenous vein. Jpn J Pharmacol 69: 391-398, 1995.
26. Pollock DM. Renal endothelin in hypertension. Curr Opin Nephrol Hypertens 9: 157-164, 2000.
27. Pollock DM, Allcock GH, Krishnan A, Dayton BD, and Pollock JS. Upregulation of endothelin B receptors in kidneys of DOCA-salt hypertensive rats. Am J Physiol Renal Physiol 278: F279-F286, 2000.
28. Pollock DM, Keith TL, and Highsmith RF. Endothelin receptors and calcium signaling. FASEB J 9: 1196-1204, 1995.
29. Rajagopalan S, Laursen JB, Borthayre A, Kurz S, Keiser J, Haleen S, Giaid A, and Harrison DG. Role for endothelin-1 in angiotensin II-mediated hypertension. Hypertension 30: 29-34, 1997.
30. Ruan X and Arendshorst WJ. Calcium entry and mobilization signaling pathways in ANG II-induced renal vasoconstriction in vivo. Am J Physiol Renal Fluid Electrolyte Physiol 270: F398-F405, 1996.
31. Salomonsson M and Arendshorst WJ. Calcium recruitment in renal vasculature: NE effects on blood flow and cytosolic calcium concentration. Am J Physiol Renal Physiol 276: F700-F710, 1999.
32. Schroeder AC, Imig JD, LeBlanc EA, Pham BT, Pollock DM, and Inscho EW. Endothelin-mediated calcium signaling in preglomerular smooth muscle cells. Hypertension 35: 280-286, 2000.
33. Takenaka T, Epstein M, Forster H, Landry DW, Iijima K, and Goligorsky MS. Attenuation of endothelin effects by a chloride channel inhibitor, indanyloxyacetic acid. Am J Physiol Renal Fluid Electrolyte Physiol 262: F799-F806, 1992.
34. Takenaka T, Forster H, and Epstein M. Protein kinase C and calcium channel activation as determinants of renal vasoconstriction by angiotensin II and endothelin. Circ Res 73: 743-750, 1993.
35. 2+ and contractile responses of resistance vessels of WKY rats and SHR to endothelin-1. J Cardiovasc Pharmacol 26 Suppl 3: S193-S196, 1995.
36. Wu-Wong JR, Chiou W, Magnuson SR, Bianchi BR, and Lin CW. Human astrocytoma U138MG cells express predominantly type-A endothelin receptor. Biochim Biophys Acta 1311: 155-163, 1996.
37. Wu-Wong JR, Chiou WJ, Magnuson SR, and Opgenorth TJ. Endothelin receptor agonists and antagonists exhibit different dissociation characteristics. Biochim Biophys Acta 1224: 288-294, 1994.
38. 2+-dependent pathway. Am J Physiol Cell Physiol 271: C869-C877, 1996.